8 June 2023
R.E.A. Holdings plc (“REA” or the “company”) AGM statement The company will hold its AGM at 10 a.m. today when the chairman will give the following…
8 June 2023 M&G plc Q1 2023 trading statement Continued positive momentum across all three Group priorities: Financial strength, Simplification and Growth Delivered positive…
7 June 2023
7 June 2023 James Cropper plc (‘James Cropper’, the ‘Company’ or the ‘Group’) TFP HYDROGEN ANNOUNCES EXPANSION OF ELECTROLYSER COATING CAPACITY IN NORTH…
07 June 2023 Concurrent Technologies Plc (“Concurrent” or the “Company”) Concurrent Technologies Announce New Distributor Agreement with SoC-e Expanding Our Portfolio with Advanced Networking…
European Commission authorises GSK’s Arexvy, the first respiratory syncytial virus (RSV) vaccine for older adults · Authorisation will help protect adults 60 years of age and older…
GSK receives US FDA file acceptance for Jemperli (dostarlimab) plus chemotherapy for the treatment of dMMR/MSI-H primary advanced or recurrent endometrial cancer · Submission accepted for Priority…
6 June 2023
HIGHLIGHTS – Total return to shareholders 16.0% (Benchmark 8.6%) – Ordinary dividend 4.0p Legal Entity Identifier: 549300D8SPJFHBDGXS57 Information disclosed in accordance with DTR 4.1 CHAIR’S STATEMENT Introduction…
2023 H1 Pre-Close Trading Update: On track to meet full year guidance 06 June 2023 Trading update – ahead of closed period commencing 26 June…